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Abstract 
P-alaxin, an artemisinin based combined therapy is very effective in treating malaria infection in areas of high 
resistance to conventional antimalarial drugs. It is a potentially promising anti-malaria drug that is composed of 
dihydroartemisinin and piperaquine phosphate. The present study investigates the fertility effects of therapeutic 
dose of P-alaxin. Fifteen male adult wistar rats of weighing between 150 and 210gm were grouped into three 
consisting of 5 males per group. The control group was orally administered with normal saline, the test and 
recovery groups were given body weight 15.4mg/kg of P-alaxin orally for three days after which the recovery 
group was allowed to recover from the drug’s effect for another three days. The animals were sacrificed twenty 
four (24) hours after the experiment.  The blood samples were collected through cardiac puncture.The result 
showed significant difference (p ≤0.05) in sperm count, sperm motility, sperm viability as well as in serum 
testosterone level of the male rats administered with P- alaxin and the recovery group when compared with the 
control group.The results suggest that oral administration of P – alaxin has significant negative effects (P <0.05) 
on sperm parameters and serum testosterone and could reduce male wistar rats fertility. 
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Introduction 
Malaria is an important tropical mosquito-borne infection affecting millions of people around the world. It is a 
mosquito-borne infectious disease of humans and other animals caused by Plasmodia and are also definitely the 
single most destructive and dangerous infectious agent in the developing countries of the world (Olayinka and 
Ore, 2013). There are many health effects of this infection.  Artemisinin and their derivatives have been 
recommended for the treatment of severe and complicated malaria. They are very active anti-malaria drugs 
producing up to ten thousand fold reductions in parasite biomass per a sexual cycle and they reduce malaria 
transmissibility (White, 1999). 
P-alaxin is a film coated tablet containing 320mg of Dihydroartemisinin (DHA) and 40mg of 
piperaquine phosphate (PQP). The drug combination is known to be effective against P. vivax, P. malariae and 
the multi-resistant P. falciparum malaria parasites. (Song et al., 2003, Olayinka and Ore 2013) 
Dihydroartemisinin is the active metabolite of artemisinin and its derivatives. These derivatives have 
more potent blood schizonticidal activity than the parent compound. Dihydroartemisinin is the most potent 
antimalarial of this group of compounds but it is also the least stable. Oral dihydroartemisinin is rapidly absorbed 
and has a short elimination half-life (Song et al., 2003). 
Piperaquine phosphate, a bisquinoline, structurally related to chloroquine has been shown to exhibit 
cardiovascular toxicity in overdose with significant electrophysiological effects on the ear (Davis et al., 2005). 
The structural determinant of the activity of artemisinins is the endoperoxide bridge which is a specific 
feature of this type of compounds. It has been suggested that the parasiticidal activity starts with the reaction of 
artemisinins with haem iron, leading to the generation of activated oxygen species, such as oxygen radicals 
(Mann et al., 200). Nosten and White (Nosten and White, 2007), had reported that if there is any toxicity 
observed in artemisinin combination treatments, it may be due to the non-artemisinin component as artemisinin 
derivatives alone may have relatively low toxicological effects. 
Decreased semen quality in malarial infected male has been reported (Singer et al., 1987). Many anti-
malaria and antibiotic agents have been reported to have anti-fertility actions. The anti -steroidogenic and anti-
fertility actions of quinine, chloroquine and artemether have been well documented (Meisel et. al., 1993; Adeeko 
and Dada, 1998; Raji et al., 2005). With the increased efforts in the development of more potent anti-malaria 
agents as a result of the challenge posed by the resistant strains of the malaria parasite, the evaluation of these 
anti-malaria agents for possible anti-fertility actions becomes important, this is necessary since both malaria and 
infertility are worldwide phenomena and the need to avoid the risk of infertility resulting from malaria 
chemotherapy. Whereas P- alaxin is becoming popular as an antimalalrial drug with remarkable efficacy, there is 
paucity of information in the literature on the possible anti- fertility effect of its administration and this is the 
objective of this current study. 
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MATERIALS AND METHODS 
EXPERIMENTAL DESIGN 
P-Alaxin tablet used for this project was obtained from Bliss GVS Pharma Limited, India. Fifteen adult male 
wistar strain rats weighing between 150 and 210gm were obtained from the Animal House of the Physiology 
Department, Olabisi Onabanjo University, Ikenne, Ogun State.  The rats were fed with standard rat pellets (Top 
Feed Nigeria Ltd., Ibadan, Nigeria) and water ad libitum. They were housed in individual wire cages in a 
temperature and humidity controlled room, having a 12-h light and dark cycle.   
The control group (5 male wistar rats) was orally administered with normal saline. The test (5 male 
wistar rats) and the recovery groups (5 male wistar rats) were orally administered with 15.4mg/kg body weight 
of P-alaxin each for three days.  After the last administration, the recovery group was allowed to recover from 
the drug’s effect for another three days.  
Animal Ethics: 
All procedures involving animals in this study conformed to the guiding principles for research involving 
animals as recommended by the Declaration of Helsinki and the Guiding Principles in the Use of Animals. 
(American Physiological Society, 2002). 
Analytical procedure 
Twenty four (24) hours after the last administration the animals were anaesthetized using diethyl ether and the 
blood collected by cardiac puncture.  
Determination of serum testosterone: Serum obtained from the blood collected via cardiac puncture was used 
to measure the level of testosterone using the Enzyme Immuno Assay (EIA) technique as previously described 
(Raji et al., 2005). 
Determination of sperm viability: The sperm viability was determined using Eosin/Nigrosin stain (Raji et 
al, 2003). 
Determination of sperm motility: A simple classification system proposed by the World Health Organization 
(Raji et al., 2005), which provides the best possible assessment of sperm motility, was used. 
Determination of sperm count: The new improved Naubauers counting chamber was used in the determination 
of sperm count. Drops of semen were placed in the chamber and a cover slip was applied. This was placed under 
light microscope and spermatozoa counted on each of the five squares. 
Sperm pH: The pH was determined by using narrow range litmus paper. 
  
STATISTICAL ANALYSIS 
The values are expressed as Mean ± S.D (standard deviation of mean). The means of the groups were compared 
using one way ANOVA (analysis of variance) and level of significance was done using least significant 
difference (LSD) and Duncan multiple range test (DMRT) at P< 0.05. 
 
RESULTS 
Effect of P- alaxin on Sperm parameters: The results are shown in Table 1.  
Effect of P-alaxin on sperm parameters (sperm counts, viability, motility and pH): 
Administration of P- alaxin at 15.4mg/kg body weight for three days significantly reduced (p<0.05) the 
progressive sperm motility, sperm count and viability when compared with the control. There was no significant 
change in values of pH of the treated rats’ semen when compared with the control. Drug withdrawal resulted in 
gradual restoration of sperm parameters in the male rats.  
Effect of P- alaxin on serum testosterone level: Serum testosterone level of P- alaxin  
treated rats significantly reduced (p<0.05) when compared to the control. However, there  
was an appreciable increase in serum testosterone levels of rats in recovery group (Table  
2). 
Table 1: Effect of P- alaxin on sperm parameters after 3 days treatments and 3 days of recovery 
Groups Sperm motility (%) Sperm count 
(106/mL) 
Sperm Viability 
(%) 
pH 
 
Control 
 
81.00 + 4.18 
 
79.20  + 5.26 
 
86.00 + 2.24 
 
7.50 + 0.16 
 
Test 
 
70.OO +  5.70* 
 
50.60 + 7.40* 
 
66.00 + 5.70* 
 
7.30  + 0.22 
 
Recovery 
 
78.00  + 3.54* 
 
67.60  + 12.24* 
 
81.00  + 3.54* 
 
7.78 +  0.29 
*P < 0.05 (p is significant at p < 0.05) 
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Table 2: Effect of P – alaxin on serum testosterone levels 
 
Groups 
 
Testosterone  (nmol/L) 
 
Control 
 
2.75 +  0.03 
 
Test 
 
1.49 +  0.02* 
 
Recovery 
 
1.67 +   0.04* 
*P < 0.05 (p is significant at p < 0.05). 
 
Discussion 
Decrease in fertility after treatment of male rats with Chloroquine and Halofantrine have been reported to be due 
to impairment in sperm motility (Adeeko and Dada, 1998. Orisakwe et. al., 2003; Raji et al., 2005). Treatment 
with such antimalarial drugs results in reducing the sperm count, motility, fertility and viability, as well as in 
serum testosterone level. It has been suggested that these drugs cause androgen depletion at the targets levels and 
particularly in the caudal epididymis, thereby affecting the physiological maturation of sperm (Adeeko and Dada, 
1998). 
The result of this present study revealed that P- alaxin could cause reproductive impairment in male 
rats. The significant reduction in the sperm motility of rat that was treated suggests that the drug was able to 
permeate the blood-testis barriers. The decrease in sperm motility caused by chemical agents has earlier been 
reported to be due to their ability to permeates the blood-testis bearer (Baldessarini, 1980) and thus, creating a 
different microenvironment in the inner part of the wall of the seminiferous tubules from that in its outer part 
(Bloom and Faweett, 1995). 
Drugs that affect the testicular functions will affect the quality and quantity of spermatozoa. The mean 
epididymal sperm number was significantly reduced (P<0.05) in all the treated groups. There was also a 
significant decrease in serum levels of testosterone in all the treated rats when compared with the control. The 
significant difference in the sperm motility, viability and counts of the rats provides evidence for the significant 
reductions in the circulating androgen levels. Testosterone is required for the growth and in association with 
follicle stimulating hormone, acts on the seminiferous tubules to initiate and maintain spermatogenesis 
(Christensen, 1975). 
In this study, the decreased sperm count, motility and viability, may have resulted from the alteration 
in the epididymal milieu, probably due to androgen deficiency (significant decrease in serum testosterone is 
observed) consequent to the anti-androgenic property of P- alaxin. 
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